1. Home
  2. SNY vs SOUNW Comparison

SNY vs SOUNW Comparison

Compare SNY & SOUNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SOUNW
  • Stock Information
  • Founded
  • SNY 1994
  • SOUNW 2005
  • Country
  • SNY France
  • SOUNW United States
  • Employees
  • SNY N/A
  • SOUNW 842
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SOUNW EDP Services
  • Sector
  • SNY Health Care
  • SOUNW Technology
  • Exchange
  • SNY Nasdaq
  • SOUNW Nasdaq
  • Market Cap
  • SNY 113.4B
  • SOUNW N/A
  • IPO Year
  • SNY N/A
  • SOUNW N/A
  • Fundamental
  • Price
  • SNY $47.03
  • SOUNW $6.49
  • Analyst Decision
  • SNY Buy
  • SOUNW
  • Analyst Count
  • SNY 4
  • SOUNW 0
  • Target Price
  • SNY $61.50
  • SOUNW N/A
  • AVG Volume (30 Days)
  • SNY 2.8M
  • SOUNW 104.1K
  • Earning Date
  • SNY 10-24-2025
  • SOUNW 02-27-2025
  • Dividend Yield
  • SNY 3.40%
  • SOUNW N/A
  • EPS Growth
  • SNY 118.56
  • SOUNW N/A
  • EPS
  • SNY 8.65
  • SOUNW N/A
  • Revenue
  • SNY $53,714,621,258.00
  • SOUNW $67,297,000.00
  • Revenue This Year
  • SNY $2.01
  • SOUNW N/A
  • Revenue Next Year
  • SNY $6.82
  • SOUNW N/A
  • P/E Ratio
  • SNY $10.74
  • SOUNW N/A
  • Revenue Growth
  • SNY 15.65
  • SOUNW 76.05
  • 52 Week Low
  • SNY $44.73
  • SOUNW $4.84
  • 52 Week High
  • SNY $60.12
  • SOUNW $6.16
  • Technical
  • Relative Strength Index (RSI)
  • SNY 42.55
  • SOUNW N/A
  • Support Level
  • SNY $46.79
  • SOUNW N/A
  • Resistance Level
  • SNY $47.69
  • SOUNW N/A
  • Average True Range (ATR)
  • SNY 0.71
  • SOUNW 0.00
  • MACD
  • SNY -0.27
  • SOUNW 0.00
  • Stochastic Oscillator
  • SNY 32.62
  • SOUNW 0.00

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About SOUNW SoundHound AI Inc. Warrant

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

Share on Social Networks: